These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Impact of Cuthbertson DJ; Barriuso J; Lamarca A; Manoharan P; Westwood T; Jaffa M; Fenwick SW; Nuttall C; Lalloo F; Prachalias A; Pizanias M; Wieshmann H; McNamara MG; Hubner R; Srirajaskanthan R; Vivian G; Ramage J; Weickert MO; Pritchard DM; Vinjamuri S; Valle J; Yip VS Front Endocrinol (Lausanne); 2021; 12():654975. PubMed ID: 34163434 [TBL] [Abstract][Full Text] [Related]
5. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms. Saleh M; Bhosale PR; Yano M; Itani M; Elsayes AK; Halperin D; Bergsland EK; Morani AC Abdom Radiol (NY); 2022 Sep; 47(9):3078-3100. PubMed ID: 33095312 [TBL] [Abstract][Full Text] [Related]
6. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases. Singhi AD; Klimstra DS Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor. Ji X; Dong A; He Q; Dong H; Zuo C Clin Nucl Med; 2020 May; 45(5):e245-e248. PubMed ID: 32049733 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Lee NJ; Hruban RH; Fishman EK Abdom Radiol (NY); 2018 Nov; 43(11):3025-3034. PubMed ID: 29594467 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study. Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM; Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641 [TBL] [Abstract][Full Text] [Related]
11. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions. Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872 [TBL] [Abstract][Full Text] [Related]
12. Imaging of neuroendocrine tumors of the pancreas. Fidler JL; Johnson CD Int J Gastrointest Cancer; 2001; 30(1-2):73-85. PubMed ID: 12489582 [TBL] [Abstract][Full Text] [Related]